While the attack was limited to email address and ICC-ID data, we encourage you to be alert to scams that could attempt to use this information to obtain other data or send you unwanted email.
Unwanted side effects on the immune system could still emerge as a problem in Ariad's trials, but early data provide hope that mTOR drugs could attack other cancers as well.